Page URL:

Mitochondrial DNA test improves IVF success rates

26 October 2015
Appeared in BioNews 825

A test which measures mitochondrial DNA (mtDNA) levels in the embryo could help increase IVF success rates, scientists claim.

Researchers at the University of Oxford have found that blastocysts containing high levels of mtDNA have a reduced chance of implantation. Conversely, they found that three-day embryos with high levels of mtDNA were more likely to implant, leading them to develop a test that could be used in IVF to select embryos most likely to go on to form a pregnancy.

'No one can dispute that IVF has been tremendously successful. If you go into any classroom at least one child will have been born through IVF,' Professor Dagan Wells, NIHR Oxford Biomedical Research Centre, Oxford. 'However it is still the case that many patients don't get pregnant, and some patients have many cycles and never come away with a baby. That has high emotional and financial implications. We're not very good at picking out which embryo will give rise to a baby.'

In the study presented at the 71st Annual Meeting of the American Society for Reproductive Medicine, Professor Wells and his team used quantitative PCR and next-generation sequencing to analyse the mtDNA content of 352 blastocysts and 39 cleavage-stage embryos from 205 couples undergoing IVF. They found that blastocysts establishing viable pregnancies contained significantly lower levels of mtDNA than embryos that did not implant, observing a threshold of mtDNA quantity above which implantation did not occur.

'Based on our findings we have devised a test whereby a small number of cells, carefully removed from an embryo, can be measured for the amount of mitochondrial DNA present,' Dr Elpida Fragouli, of US firm Reprogenetics, which led the research.

The study also revealed that cleavage-stage embryos from younger women's eggs contained more mtDNA than was present in older women's eggs, but also that blastocysts contained higher levels of mtDNA the older the patient. Aneuploid embryos were also shown to contain higher levels of mtDNA, independent of the age of the patient.

Trials of the test, named MitoGrade, are currently ongoing in the USA. Data from 100 US patients suggests that MitoGrade could raise the chance of selecting a viable embryo by ten percent. Researchers are applying to the Human Fertilisation and Embryology Authority for a licence to offer the test in the UK, which would be performed alongside preimplantation genetic screening (PGS), at an estimate additional cost of £200.

Professor Tina Buchholz, scientific director of the International Federation of Fertility Societies, New Jersey, USA, who was not involved in the study, said: 'The study offers a very interesting approach and it is certainly important to follow this up. So far however, this is a small study, and doesn't provide sufficient evidence to implement in clinical practice. It is not certain whether the result in one or a few cells is reflected throughout the whole embryo. We definitively need more research on this, and at this stage, I would be cautious in predicting this as a new biomarker.'

IVF test could more than double success rate to over 80 per cent
The Independent |  20 October 2015
New British test for IVF patients could increase chance of conception by 75pc
The Telegraph |  20 October 2015
New DNA test for embryos could boost IVF success rates
The Guardian |  20 October 2015
The biological and clinical impact of mitochondrial genome variation in human embryos
American Society for Reproductive Medicine (2015 conference abstract) |  20 October 2015
The More Mitochondria in a Blastocyst, the Less Likely It Is to Implant
American Society for Reproductive Medicine (press release) |  20 October 2015
21 November 2016 - by Antony Starza-Allen 
An online calculator that can estimate the cumulative success rate of IVF over multiple cycles has been released...
23 May 2016 - by Dr Rosie Morley 
A study has identified a potential problem with mitochondrial donation, an IVF technique that aims to prevent the transmission of faulty mitochondria from mother to child...
16 May 2016 - by Paul Waldron 
A single-celled organism lacking mitochondria – cellular structures thought to be essential for all complex lifeforms – has been identified by scientists...
9 May 2016 - by James Brooks 
The UK's first baby resulting from an embryo that was screened using next-generation DNA sequencing has been born in Oxford...
1 February 2016 - by Antony Starza-Allen 
Researchers from the UK and the Netherlands have identified a 'genetic signature' in the womb that could help explain repeated IVF failure in some women....
17 August 2015 - by Kirsty Oswald 
Changes to the activity of cells in the ovary may contribute to poorer IVF success rates among women in their 40s...
27 July 2015 - by Dr Dusko Ilic 
Given the complexity of the technology, costs and risks involved, two recently described mitochondrial 'gene-correction' strategies will probably remain as proof-of-concept studies and are unlikely be of practical use in clinical medicine in the foreseeable future...
20 July 2015 - by Dr Julia Hill 
Scientists in the USA have demonstrated how stem cell techniques may benefit people with incurable mitochondrial diseases. The research suggests it might be possible one day to replace diseased tissue in patients affected by the disorders...
13 April 2015 - by Dr Rachel Montgomery 
The first baby in Europe has been born following a new IVF-based technique developed to prevent the inheritance of genetic disorders...
2 March 2015 - by Sandy Starr 
The House of Lords has voted by 280 to 48 to pass regulations permitting mitochondrial donation. This makes the UK the first country in the world to legislate for the use of mitochondrial donation techniques in treatment...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.